Loading...
Loading...
Browse all stories on DeepNewz
VisitHow will Grifols stock perform relative to IBEX 35 by June 30, 2025?
Outperform IBEX 35 • 25%
Match IBEX 35 • 25%
Underperform IBEX 35 • 25%
Significant Underperformance • 25%
Stock performance data from financial platforms like Bloomberg or Yahoo Finance
Brookfield Abandons Grifols Acquisition, Stock Plummets
Nov 27, 2024, 09:01 AM
Brookfield Asset Management is reportedly preparing to abandon its plans to acquire Spanish drug-maker Grifols SA due to disagreements over valuation. Grifols' board recently rejected Brookfield's indicative offer, leading to a significant drop in Grifols' stock price. The shares fell as much as 17% after the news broke, with the company's stock plummeting by 12% on the day. The potential withdrawal of the offer has also impacted the broader market, with the IBEX 35 index losing 11,600 points. The Grifols family has indicated they won't support a new bid by a third-party to take the company private.
View original story
Higher than competitors • 25%
On par with competitors • 25%
Lower than competitors • 25%
Significantly lower than competitors • 25%
Outperforms DAX by more than 10% • 25%
Outperforms DAX by up to 10% • 25%
Performs similar to DAX • 25%
Underperforms DAX • 25%
Decrease by more than 10% • 25%
Change between -10% and 10% • 25%
Increase by 10% to 20% • 25%
Increase by more than 20% • 25%
Significantly outperform • 25%
Slightly outperform • 25%
Match sector performance • 25%
Underperform • 25%
Outperform by more than 5% • 25%
Perform within 5% of S&P 500 • 25%
Underperform by 1-5% • 25%
Underperform by more than 5% • 25%
Outperforms NASDAQ • 25%
Performs on par with NASDAQ • 25%
Underperforms NASDAQ • 25%
Delisted from NASDAQ • 25%
Stock price increases by over 50% • 33%
Stock price remains within 20% of current value • 34%
Stock price decreases by over 20% • 33%
Stock price increases by more than 10% • 25%
Stock price remains stable • 25%
Stock price decreases by more than 10% • 25%
Stock price fluctuates but ends stable • 25%
Partnership with Another Company • 25%
New Acquisition Target • 25%
No Major Change • 25%
Restructuring Plan • 25%